Search - tctmd.com

Displaying 621 - 640 of 655

Sort: Relevancy | Date

News Daily News

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

March 07, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Daily News

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

L.A. McKeown

January 09, 2012

News Conference News

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

November 13, 2011

News Conference News

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

November 13, 2011

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

L.A. McKeown

November 01, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

Postconditioning Again Fails to Reduce Reperfusion Injury After STEMI

August 24, 2011

News Daily News

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

August 01, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Caitlin E. Cox

July 08, 2011

News Daily News

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

July 05, 2011

News Daily News

No Advantage with Facilitated PCI Even in Patients Most Likely to Benefit

Jason Kahn

June 20, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

Advertisement

Registry Confirms Bivalirudin Better for STEMI in ‘Real World’

Expedited Cell Therapy After STEMI Shows Promise

Meta-Analysis Shows Increased Risk of MI, ACS with Dabigatran

ISAR-REACT 4: Bivalirudin Reduces Major Bleeding in NSTEMI Patients

AIDA STEMI: No Advantage for Intracoronary vs. Intravenous Abciximab

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

Meta-analysis: Intracoronary vs. IV Abciximab Improves Survival in STEMI Patients

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

ESC Congress 2011: Drugs, Devices Work Together

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Postconditioning Again Fails to Reduce Reperfusion Injury After STEMI

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Ticagrelor Gains FDA Approval for Use in ACS

Meta-analysis: Selective Use of Small-Molecule GPIs Best in NSTE ACS Patients

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

No Advantage with Facilitated PCI Even in Patients Most Likely to Benefit

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

Syntax Score Predicts 1-Year Risk in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content